Trial participants who received an increased weekly dose of Wegovy lost 19 per cent of their body weight in a year on average, but also saw a higher risk of painful skin sensations and nausea
Trial participants who received an increased weekly dose of Wegovy lost 19 per cent of their body weight in a year on average, but also saw a higher risk of painful skin sensations and nausea Trial participants who received an increased weekly dose of Wegovy lost 19 per cent of their body weight in a year on average, but also saw a higher risk of painful skin sensations and nausea